Form 8-K - Current report:
SEC Accession No. 0001558370-25-011911
Filing Date
2025-09-08
Accepted
2025-09-08 09:54:50
Documents
13
Period of Report
2025-09-05
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K chrs-20250905x8k.htm   iXBRL 8-K 36811
  Complete submission text file 0001558370-25-011911.txt   158156

Data Files

Seq Description Document Type Size
2 EX-101.SCH chrs-20250905.xsd EX-101.SCH 4286
3 EX-101.DEF chrs-20250905_def.xml EX-101.DEF 3588
4 EX-101.LAB chrs-20250905_lab.xml EX-101.LAB 17206
5 EX-101.PRE chrs-20250905_pre.xml EX-101.PRE 11370
15 EXTRACTED XBRL INSTANCE DOCUMENT chrs-20250905x8k_htm.xml XML 4852
Mailing Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065
Business Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065 (650) 649-3530
Coherus Oncology, Inc. (Filer) CIK: 0001512762 (see all company filings)

EIN.: 273615821 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36721 | Film No.: 251298822
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)